Medicines Seized From Roorkee Unit Fail Lab Tests

Roorkee : Several packets of branded medicines, which were allegedly being manufactured in a local pharma factory, have failed lab tests. A joint team of state drug control department and police had seized a high volume of alleged fake medicines worth Rs 1.7 crore from a small-sized pharmaceutical industry in Roorkee in August this year. Police had arrested Praveen Tyagi, the owner of the pharma unit, and his aide on the day of the raid itself. A cash amount of Rs 4.65 lakh was also recovered from their possession.

According to reports, the officials from the drug control department and the local police had raided an illegal pharma manufacturing company at Madhopur village near Roorkee and seized medicines of around 200 brands worth Rs 1.7 crore. Police had recovered raw materials, wrappers, aluminium foils, and packaging materials from the spot.

“We had sent 10 samples collected from the unit. They have now been found as ‘spurious’ in the state laboratory tests. The accused Tyagi and his associate are in jail. After this report, the release of the offenders on bail would become difficult,” said MS Rana, drug inspector, Haridwar.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre